Headline
The latest stories from AHA Today.
The American Society of Addiction Medicine and the American Medical Association yesterday released an issue brief on an alternative payment model for medication-assisted therapy, and seek physician practices and insurers interested in pilot testing the model for patients with opioid use disorder.
Current state proposals to require certain Medicaid beneficiaries to participate in work, training or other “community engagement” activity to remain eligible for coverage could affect more than 1.7 million enrollees and nearly $8 billion in program expenditures.
The Centers for Medicare & Medicaid Services plans to continue periodic post-payment reviews and provider education to ensure Medicare claims for telehealth services meet program requirements, and to ensure Medicare contractors implement all planned claims edits.
AHA Senior Vice President and Chief Medical Officer Jay Bhatt, D.O., yesterday participated in a panel on building a sustainable healthy community as part of the National Minority Quality Forum’s annual conference on health disparities.
The Drug Enforcement Administration continues to adjust manufacturers’ quotas for injectable opioid pain medications.
Coastal Meds LLC, which compounds drugs as an outsourcing facility, has voluntarily recalled all of its products marketed as sterile due to visible particles in some of the drug vials for injection.
The Centers for Disease Control and Prevention has released Spanish versions of its most popular materials to educate health care providers and consumers about appropriate use of antibiotics and prevent the spread of antibiotic-resistant bacteria. Print materials also can be ordered at…
The College of Healthcare Information Management Executives recently launched the 2018 Most Wired Survey, which hospitals can complete through May 31.
AHA is asking hospitals and health systems to submit photos by May 1 showing their commitment to combating violence.
The Centers for Medicare & Medicaid Services is appealing a federal court decision that barred the agency from enforcing in Missouri a 2017 final rule and earlier guidance.